Quick Answer
Emergent BioSolutions Inc. reported Diluted EPS of $3.60 per share (loss) for fiscal year 2024.
Emergent BioSolutions Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$3.60 | +75.8% |
| 2023 | -$14.85 | -251.9% |
| 2022 | -$4.22 | -203.9% |
| 2021 | $4.06 | -28.4% |
| 2020 | $5.67 | +445.2% |
| 2019 | $1.04 | -14.8% |
| 2018 | $1.22 | -28.7% |
| 2017 | $1.71 | +51.3% |
| 2016 | $1.13 | -19.9% |
| 2015 | $1.41 | +60.2% |
| 2014 | $0.88 | +3.5% |
| 2013 | $0.85 | +30.8% |
| 2012 | $0.65 | +1.6% |
| 2011 | $0.64 | -59.7% |
| 2010 | $1.59 | +60.6% |
| 2009 | $0.99 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.91 | -55.8% | +513.6% |
| June 30, 2025 | -$0.22 | +95.9% | -118.5% |
| March 31, 2025 | $1.19 | +600.0% | -42.2% |
| September 30, 2024 | $2.06 | +140.6% | +138.3% |
| June 30, 2024 | -$5.38 | -4.3% | -3264.7% |
| March 31, 2024 | $0.17 | +104.6% | +103.3% |
| September 30, 2023 | -$5.08 | -190.3% | +1.6% |
| June 30, 2023 | -$5.16 | -386.8% | -39.1% |
- Emergent BioSolutions Inc. showed an increase of +75.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2024 period, Emergent BioSolutions Inc.’s diluted eps has declined by 463.6% (from $0.99 per share to $3.60 per share (loss)).
- The most recent figure is from Emergent BioSolutions Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 4, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: